ERBB2 and breast carcinoma: The mRNA expression of all candidates, in comparision with GAPDH, was analyzed in basal type (MDA-MB-231) and hormone positive (HR(+)), HER2 negative (HER2 (−)) type MCF7 breast cancer cell lines.